Trials / Completed
CompletedNCT01370707
A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients
A Randomized, Double-blind, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Patients With Type 2 Diabetes and Inadequate Glycemic Control ; Phase III Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 187 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 20 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy and safety fo CJ-30001/CJ-30002.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | 1000\~1500mg/day, 24weeks |
| DRUG | CJ-30001/CJ-30002 | 0.6/1500mg\~0.9/1500mg/day, 24weeks |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-06-10
- Last updated
- 2013-02-15
Locations
21 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01370707. Inclusion in this directory is not an endorsement.